Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Predictors of resolution and persistence of renal laboratory abnormalities in pediatric HIV infection.

Mitchell CD, Chernoff MC, Seage GR 3rd, Purswani MU, Spiegel HM, Zilleruelo G, Abitbol C, Heckman B, Ponce CB, Oleske JM; IMPAACT 219/219C Study Team.

Pediatr Nephrol. 2015 Jan;30(1):153-65. doi: 10.1007/s00467-014-2909-1. Epub 2014 Aug 24.

2.

Medication adherence in children and adolescents with HIV infection: associations with behavioral impairment.

Malee K, Williams P, Montepiedra G, McCabe M, Nichols S, Sirois PA, Storm D, Farley J, Kammerer B; PACTG 219C Team.

AIDS Patient Care STDS. 2011 Mar;25(3):191-200. doi: 10.1089/apc.2010.0181. Epub 2011 Feb 16.

3.

Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication.

Watts DH, Huang S, Culnane M, Kaiser KA, Scheuerle A, Mofenson L, Stanley K, Newell ML, Mandelbrot L, Delfraissy JF, Cunningham CK.

J Perinat Med. 2011 Mar;39(2):163-70. doi: 10.1515/JPM.2010.139. Epub 2010 Dec 13.

4.

Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.

Chalermchockcharoenkit A, Culnane M, Chotpitayasunondh T, Vanprapa N, Leelawiwat W, Mock PA, Asavapiriyanont S, Teeraratkul A, McConnell MS, McNicholl JM, Tappero JW.

Clin Infect Dis. 2009 Jul 15;49(2):299-305. doi: 10.1086/599612.

5.

Dried blood spots for the diagnosis and quantitation of HIV-1: stability studies and evaluation of sensitivity and specificity for the diagnosis of infant HIV-1 infection in Thailand.

Leelawiwat W, Young NL, Chaowanachan T, Ou CY, Culnane M, Vanprapa N, Waranawat N, Wasinrapee P, Mock PA, Tappero J, McNicholl JM.

J Virol Methods. 2009 Feb;155(2):109-17. doi: 10.1016/j.jviromet.2008.09.022. Epub 2008 Nov 18.

PMID:
18952125
6.

Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection.

Supapol WB, Remis RS, Raboud J, Millson M, Tappero J, Kaul R, Kulkarni P, McConnell MS, Mock PA, Culnane M, McNicholl J, Roongpisuthipong A, Chotpitayasunondh T, Shaffer N, Butera S.

J Infect Dis. 2008 May 15;197(10):1369-77. doi: 10.1086/587488.

7.

Assessment of bacille Calmette-Guérin vaccine reaction in HIV-exposed Thai infants.

Chokephaibulkit K, Chotpitayasunondh T, Vanprapar N, Waranawat N, Mock PA, McConnell MS, Jetswang B, Neeyapun K, Tappero JW, Culnane M.

Clin Infect Dis. 2007 Oct 15;45(8):1016-8. Epub 2007 Sep 14.

8.

Reduction in mother-to-child transmission of HIV in Thailand, 2001-2003: Results from population-based surveillance in six provinces.

Plipat T, Naiwatanakul T, Rattanasuporn N, Sangwanloy O, Amornwichet P, Teeraratkul A, Ungchusak K, Mock P, Levine W, McConnell MS, Simonds R, Culnane M.

AIDS. 2007 Jan 11;21(2):145-51.

PMID:
17197804
9.

Factors associated with non-disclosure of HIV infection status of new mothers in Bangkok.

Skunodom N, Linkins RW, Culnane ME, Prymanee J, Kannasoot C, Suwannapha W, Suwanmaitre S, Utenpitak C, Yuvasevee C, Teeraratkul A, Simonds RJ, Tappero JW.

Southeast Asian J Trop Med Public Health. 2006 Jul;37(4):690-703.

PMID:
17121295
10.

Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implications for future HPV immunization.

Bollen LJ, Chuachoowong R, Kilmarx PH, Mock PA, Culnane M, Skunodom N, Chaowanachan T, Jetswang B, Neeyapun K, Asavapiriyanont S, Roongpisuthipong A, Wright TC, Tappero JW.

Sex Transm Dis. 2006 Apr;33(4):259-64.

PMID:
16452834
11.

Evaluating programs to prevent mother-to-child HIV transmission in two large Bangkok hospitals, 1999-2001.

Teeraratkul A, Simonds RJ, Asavapiriyanont S, Chalermchokcharoenkit A, Vanprapa N, Chotpitayasunondh T, Mock PA, Skunodum N, Neeyapun K, Jetsawang B, Culnane M, Tappero J; Bangkok Collaborative Perinatal HIV Transmission Study Group.

J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):208-12.

PMID:
15671807
12.

Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316.

Watts DH, Balasubramanian R, Maupin RT Jr, Delke I, Dorenbaum A, Fiore S, Newell ML, Delfraissy JF, Gelber RD, Mofenson LM, Culnane M, Cunningham CK; PACTG 316 Study Team.

Am J Obstet Gynecol. 2004 Feb;190(2):506-16.

PMID:
14981398
13.

Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: association with timing of maternal intrapartum nevirapine dose.

Mirochnick M, Dorenbaum A, Blanchard S, Cunningham CK, Gelber RD, Mofenson L, Culnane M, Sullivan JL.

J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):153-6.

PMID:
12794547
14.

Concentrations of protease inhibitors in cord blood after in utero exposure.

Mirochnick M, Dorenbaum A, Holland D, Cunningham-Schrader B, Cunningham C, Gelber R, Mofenson L, Culnane M, Connor J, Sullivan JL.

Pediatr Infect Dis J. 2002 Sep;21(9):835-8.

PMID:
12352805
15.

Preventing mother-to-child HIV transmission: the first year of Thailand's national program.

Amornwichet P, Teeraratkul A, Simonds RJ, Naiwatanakul T, Chantharojwong N, Culnane M, Tappero JW, Kanshana S.

JAMA. 2002 Jul 10;288(2):245-8.

PMID:
12095391
16.

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.

Dorenbaum A, Cunningham CK, Gelber RD, Culnane M, Mofenson L, Britto P, Rekacewicz C, Newell ML, Delfraissy JF, Cunningham-Schrader B, Mirochnick M, Sullivan JL; International PACTG 316 Team.

JAMA. 2002 Jul 10;288(2):189-98.

PMID:
12095383
17.

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

Tuomala RE, Shapiro DE, Mofenson LM, Bryson Y, Culnane M, Hughes MD, O'Sullivan MJ, Scott G, Stek AM, Wara D, Bulterys M.

N Engl J Med. 2002 Jun 13;346(24):1863-70.

18.

Attempting to enhance the enrollment of adolescents into AIDS clinical trials: the design of ACTG Protocol 220.

D'Angelo LJ, Lindsey J, Zimmer B, Culnane M, Futtermann D.

AIDS Patient Care STDS. 1998 Nov;12(11):853-9.

PMID:
11362042
19.

Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials Group.

Frenkel LM, Capparelli EV, Dankner WM, Xu J, Smith IL, Ballow A, Culnane M, Read JS, Thompson M, Mohan KM, Shaver A, Robinson CA, Stempien MJ, Burchett SK, Melvin AJ, Borkowsky W, Petru A, Kovacs A, Yogev R, Goldsmith J, McFarland EJ, Spector SA.

J Infect Dis. 2000 Dec;182(6):1616-24. Epub 2000 Nov 8.

20.

Single-dose pharmacokinetics and safety of the oral antiviral compound adefovir dipivoxil in children infected with human immunodeficiency virus type 1. The Pediatrics AIDS Clinical Trials Group.

Hughes WT, Shenep JL, Rodman JH, Fridland A, Willoughby R, Blanchard S, Purdue L, Coakley DF, Cundy KC, Culnane M, Zimmer B, Burchett S, Read JS.

Antimicrob Agents Chemother. 2000 Apr;44(4):1041-6.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk